ArticleFrontiers in psychology2026
Onco-anxiology: a proposal for an anxiety-focused, longitudinal framework within cancer care.
Article in Frontiers in psychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Anxiety is among the most common forms of psychological distress in people with cancer, yet in routine practice it is usually addressed within a broad "distress" construct rather than as a distinct clinical target. Objective: This Perspective examines whether anxiety warrants a dedicated, longitudinally organised clinical focus, and proposes onco-anxiology as such a framework within psycho-oncology. Key points: Anxiety in cancer is phenomenologically distinct from depression, frequently oriented toward realistic future threat such as fear of cancer recurrence, follows a patterned course at the population level, and is shaped by cancer-specific mechanisms, including conditioned anticipatory symptoms and the overlap between somatic anxiety items and treatment side effects; existing screening is generally organised around undifferentiated distress rather than anxiety specifically, and unaided clinician recognition and help uptake are limited. Onco-anxiology is defined by three commitments: anxiety-specific targeting, a longitudinal lens, and explicit attention to cancer-specific anxiety mechanisms. Physiological measurement is positioned as a research direction and an optional adjunct rather than a defining feature, and the framework is offered as a way of organising care within psycho-oncology rather than as a claim to a new sub-specialty. Conclusion: A focused framework may improve identification and treatment of anxiety in oncology. The term is proposed as a testable organising concept, not an established field, and a research agenda is outlined.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.